A Study of Predictors of Renal Insufficiency Following Orthotopic Liver Transplantation


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-002305
    Sponsor Protocol Number: 16-002305

About this study

The purpose of this study is to see if certain pre-transplant markers are able to predict how the kidney will respond after a liver transplant.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria

  • Adult, >18 years
  • ESLD
  • Superimposed hepatocellular carcinoma within the Milan criteria
  • Primary LTx (no repeat LTx)
  • Simultaneous liver-kidney transplant

Exclusion Criteria

  • Acute fulminant hepatic failure, status 1
  • CKD requiring dialysis > 6 months
  • Solitary kidney

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Julie Heimbach, M.D.

Closed for enrollment

Contact information:

Thomas De Leeuw